Skip to content
Tech News
← Back to articles

Evolutionary mystery revealed by structures of a key enzyme in the synthesis of glycolipids

read original more articles
Why This Matters

The detailed structural insights into the enzyme UGCG enhance our understanding of glycosphingolipid biosynthesis, which is crucial for cell function and disease development. This knowledge could lead to targeted therapies for conditions involving lipid metabolism and pave the way for novel drug design. Understanding primate-specific features also offers evolutionary insights with potential biomedical implications.

Key Takeaways

Cells produce hundreds of different sugar-bearing lipids called glycosphingolipids. The synthesis of almost all of them traces back to a single enzyme: UDP-glucose ceramide glucosyltransferase (UGCG), which catalyses a key early step in the glycosphingolipid biosynthetic pathway. How this gatekeeper enzyme works at the molecular level has been unclear for decades. Writing in Nature, Wu et al.1 present eight structures of UGCG in various functional states, which reveal an unforeseen catalytic mechanism, information about how therapeutic drugs inhibit the enzyme and a ‘brake’ feature found only in primate UGCGs.

doi: https://doi.org/10.1038/d41586-026-02378-8

References Wu, C. et al. Nature https://doi.org/10.1038/s41586-026-10927-4 (2026). Hannun, Y. A. & Obeid, L. M. Nature Rev. Mol. Cell Biol. 19, 175–191 (2018). Merrill, A. H. Jr Chem. Rev. 111, 6387–6422 (2011). Platt, F. M. Nature 510, 68–75 (2014). Sidransky, E. et al. N. Engl. J. Med. 361, 1651–1661 (2009). Cox, T. M. et al. Lancet 385, 2355–2362 (2015). Peterschmitt, M. J. et al. Clin. Pharmacol. Drug Dev. 10, 86–98 (2020). Platt, F. M., Neises, G. R., Dwek, R. A. & Butters, T. D. J. Biol. Chem. 269, 8362–8365 (1994). Download references

Competing Interests The authors declare no competing interests.

Related Articles

Subjects